Stealth BioTherapeutics
Biotechnology Research • 
Needham, Massachusetts, United States • 51-100 Employees
Company overview
| Headquarters | 123 Highland Ave, Suite 201, Needham, Massachusetts 02494, US |
| Phone number | +16176006888 |
| Website | |
| SIC | 283 |
| Founded | 2007 |
| Employees | 51-100 |
| Socials |
Key Contacts at Stealth BioTherapeutics
Amy Meadowcroft
Executive Director, Clinical Development
Katherine Landes
Executive Director
Kevin F. Mclaughlin
Member Board Of Directors
Edwin Obana
Director, Scientific Communications, Medical Affairs
Mitesh Chauhan
Director Of Adqc
Hess Suh
Executive Director Of Regulatory Affairs
John Ciallella
Senior Director Of Toxicology And Drug Development
Donna Cowan
Director Expanded Access Programs & Registry
James D. Wakefield
Senior Director, Clinical Pharmacology And Dmpk
Guo Zhu Zheng
Executive Director
Stealth BioTherapeutics Email Formats
Stealth BioTherapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@stealthbt.com), used 62.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@stealthbt.com | 62.2% |
{first initial}.{last name} | j.doe@stealthbt.com | 37.8% |
About Stealth BioTherapeutics
Our Mission Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address. We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates. Please be aware ofthepotential forscams claiming to represent Stealth BioTherapeutics in recruitment activities. Stealth exclusively uses @stealthbt.com e-mail addresses for recruitment purposes and doesnotconduct interviews viasocial media or other third-party sites. Please report any suspicious recruiting activity to us at careers@stealthbt.com and to the Internet Crime Complaint Center.
Stealth BioTherapeutics revenue & valuation
| Annual revenue | $21,100,000 |
| Revenue per employee | $370,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $67,500,000 |
| Total funding | $8,500,000 |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Stealth BioTherapeutics has 32 employees across 8 departments.
Departments
Number of employees
Stealth BioTherapeutics Tech Stack
Discover the technologies and tools that power Stealth BioTherapeutics's digital infrastructure, from frameworks to analytics platforms.
Widgets
JavaScript libraries
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Programming languages
Blogs
SEO
Analytics
Video players
UI frameworks
India
Australia
Cyprus
United Kingdom
Frequently asked questions
4.8
40,000 users
